Jodas Expoim Private Limited — Gefitinib Exporter Profile
Indian Pharmaceutical Exporter · #3 for Gefitinib · $395.7K export value · DGFT Verified
Jodas Expoim Private Limited is the #3 Indian exporter of Gefitinib with $395.7K in export value and 11 verified shipments. Jodas Expoim Private Limited holds a 5.8% market share in Gefitinib exports across 5 countries. The company exports 33 pharmaceutical products worth $24.4M across 8 therapeutic categories.
Jodas Expoim Private Limited — Gefitinib Export Profile: Buyers & Destinations
Where Does Jodas Expoim Private Limited Export Gefitinib?
| Country | Value | Shipments | Share |
|---|---|---|---|
| RUSSIA | $100.0K | 2 | 55.3% |
| VIETNAM DEMOCRATIC REP OF | $50.0K | 1 | 27.7% |
| SRI LANKA | $16.6K | 4 | 9.2% |
| PAKISTAN | $10.5K | 3 | 5.8% |
| PHILIPPINES | $3.6K | 1 | 2.0% |
Jodas Expoim Private Limited exports Gefitinib to 5 countries. The largest destination is RUSSIA accounting for 55.3% of Jodas Expoim Private Limited's Gefitinib shipments, followed by VIETNAM DEMOCRATIC REP OF (27.7%) and SRI LANKA (9.2%). These destinations reflect Jodas Expoim Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Gefitinib from Jodas Expoim Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| OOOJODAS EXPOIM | RUSSIA | $100.0K | 2 |
| HATAY PHARMACEUTICAL JOINT STOCK | VIETNAM DEMOCRATIC REP OF | $50.0K | 1 |
| SOFTCARE INTERNATIONAL(PVT)LTD | SRI LANKA | $10.8K | 2 |
| JS BANK LIMITED, | PAKISTAN | $10.5K | 3 |
| SOFTCARE INTERNATIONAL PRIVATE LIMITED | SRI LANKA | $4.3K | 1 |
| BLISS PHARMA DISTRIBUTION AND | PHILIPPINES | $3.6K | 1 |
| SOFTCARE INTERNATIONAL(PRIVATE)LIMITED | SRI LANKA | $1.5K | 1 |
Jodas Expoim Private Limited supplies Gefitinib to 7 buyers globally. The largest buyer is OOOJODAS EXPOIM (RUSSIA), followed by HATAY PHARMACEUTICAL JOINT STOCK (VIETNAM DEMOCRATIC REP OF) and SOFTCARE INTERNATIONAL(PVT)LTD (SRI LANKA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Gefitinib Export Value and How Much Does Jodas Expoim Private Limited Contribute?
India exported $2.6M worth of Gefitinib through 297 shipments from 80 suppliers to 47 countries, serving 135 buyers globally. Jodas Expoim Private Limited contributes $395.7K to this total, accounting for 5.8% of India's Gefitinib exports. Jodas Expoim Private Limited ships Gefitinib to 5 countries through 7 buyers.
What Is the Average Shipment Value for Jodas Expoim Private Limited's Gefitinib Exports?
Jodas Expoim Private Limited's average Gefitinib shipment value is $36.0K per consignment, based on 11 shipments totaling $395.7K. The largest destination is RUSSIA (55.3% of Jodas Expoim Private Limited's Gefitinib exports).
How Does Jodas Expoim Private Limited Compare to Other Indian Gefitinib Exporters?
Jodas Expoim Private Limited ranks #3 among 80 Indian Gefitinib exporters with a 5.8% market share. The top 3 exporters are CIPLA LIMITED ($1.1M), NATCO PHARMA LIMITED ($500.0K), JODAS EXPOIM PRIVATE LIMITED ($395.7K). Jodas Expoim Private Limited processed 11 shipments to 5 destination countries.
What Gefitinib Formulations Does Jodas Expoim Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| GEFITINIB TABLETS 250MG (30 TABLETS IN ONE HDPE BOTTLE) (AS PER INVOICE) | $50.0K | 1 |
| GEFITINIB TABLETS 250MG (30 TABLETS IN ONE HDPE BOTTLE)(AS PER INVOICE) | $50.0K | 1 |
| GEFIRESSA GEFITINIB TABLETS 250MG 3 X10 ALU PVC BLISTER PACK 5000 PACKS X3X10 S 150000 NOS | $50.0K | 1 |
| GEFITINIB TABLETS 250MG (30 TABLETS IN ONE HDPE BOTTLE) (AS PER INVOICE)TBS | $19.6K | 4 |
| GEFITINIB TABLETS 250MG 1X10'S BLISTERPACK AS PER DOCUMENT | $4.3K | 1 |
| GEFITINIB TABLETS 250MG (3X10 TABLETS ALU-PVC BLISTER PACKS) [QUALITINIB] (QTY:100 PACKS X 30 S = 3000 NOS)NOS | $3.6K | 1 |
| GEFITINIB TABLETS 250MG (30 TABLETS IN HDPE BOTTLE)(AS PER INVOICE)TBS | $1.8K | 1 |
| GEFITINIB TABLETS 250MG (30 TABLETS IN ONE HDPE BOTTLE (AS PER INVOICE) | $1.5K | 1 |
Jodas Expoim Private Limited exports 8 distinct Gefitinib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is GEFITINIB TABLETS 250MG (30 TABLETS IN ONE HDPE BOTTLE) (AS with 1 shipments worth $50.0K.
How Does Jodas Expoim Private Limited Compare to Nearest Gefitinib Exporters?
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | CIPLA LIMITED | $1.1M | 21 | 3 | $50.0K |
| 2 | NATCO PHARMA LIMITED | $500.0K | 10 | 6 | $50.0K |
| 3 | JODAS EXPOIM PRIVATE LIMITED ★ | $395.7K | 11 | 5 | $36.0K |
| 4 | NAPROD LIFE SCIENCES PRIVATE LIMITED | $327.9K | 11 | 2 | $29.8K |
| 5 | KHANDELWAL LABORATORIES PRIVATE LIMITED | $139.8K | 11 | 1 | $12.7K |
Jodas Expoim Private Limited ranks #3 among 80 Indian Gefitinib exporters. Average shipment value of $36.0K compared to the market average of $32.6K. The closest competitors by value are CIPLA LIMITED and NATCO PHARMA LIMITED.
Which Indian Ports Ship Gefitinib Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 72 | 24.2% |
| SAHAR AIR | 56 | 18.9% |
| DELHI AIR CARGO ACC (INDEL4) | 34 | 11.4% |
| DELHI AIR | 25 | 8.4% |
| Bombay Air | 23 | 7.7% |
| AHEMDABAD AIR | 11 | 3.7% |
| Delhi Air | 10 | 3.4% |
| HYDERABAD AIR | 10 | 3.4% |
What Other Advanced Oncology Products Does Jodas Expoim Private Limited Export?
Jodas Expoim Private Limited also exports these advanced oncology products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Jodas Expoim Private Limited's Gefitinib Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Jodas Expoim. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing significant delays and increased freight costs. These maritime disruptions have the potential to jeopardize up to ₹5,000 crore (approximately $600 million) in Indian pharmaceutical exports to the Middle East, a region that accounted for $1.75 billion in exports in the 2024-25 financial year. (pharmaceuticalcommerce.com)
Conversely, the U.S. has imposed tariffs on pharmaceutical imports, affecting nearly 55% of India's outbound shipments to America. This development necessitates strategic adjustments for exporters like Jodas Expoim to maintain competitiveness in the U.S. market. (apnews.com)
In the European Union, compliance with the Falsified Medicines Directive (FMD) has become imperative. The directive mandates stringent serialization and traceability requirements to combat counterfeit drugs. For Jodas Expoim, adhering to these regulations is crucial to sustain and expand its presence in the EU market.
Jodas Expoim Private Limited — Regulatory Compliance & Quality Standards
The Indian pharmaceutical industry has faced increased scrutiny from international regulatory bodies. In 2023, the U.S. FDA conducted over 200 inspections in India, with plans to increase this number in 2024. This heightened oversight underscores the necessity for companies like Jodas Expoim to invest in robust quality control systems and ensure compliance with Good Manufacturing Practices (GMP). (fact.net.in)
The 2024 incident involving the seizure of spurious antibiotics from Jodas Expoim's facility highlights the critical importance of maintaining stringent quality standards. Such regulatory lapses can have severe repercussions, including export bans and damage to the company's reputation.
About Jodas Expoim Private Limited
Jodas Expoim Private Limited exports 33 products worth $24.4M. Beyond Gefitinib, top products include Paclitaxel, Imatinib, Capecitabine, Oxaliplatin, Gemcitabine. View the complete Jodas Expoim Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Gefitinib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Gefitinib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Jodas Expoim Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 11 individual customs records matching Jodas Expoim Private Limited exporting Gefitinib, covering 8 formulations to 5 countries via 7 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 47+ countries, 135+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Gefitinib Export Data from Jodas Expoim Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Jodas Expoim Private Limited's Gefitinib exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Jodas Expoim Private Limited
Full Company Profile →
33 products · $24.4M total trade · 8 categories
Gefitinib Stats
Company Overview
Top Products by Jodas Expoim Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Jodas Expoim Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Gefitinib. For current shipment-level data, contact TransData Nexus.